Group letter re: DEA’s proposed rule on controlled substances quotas

May 4, 2018

RE: Controlled Substances Quotas [Docket No. DEA-480]

The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas. Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion of another critical factor – drug shortages. To ensure that legitimate medical needs are met, it is imperative that drug shortages be considered as aggregate production quotas (APQ) are set and adjusted.

Read the full letter below.

Related Resources

In its fiscal year 2019 inpatient prospective payment system final rule, the Centers for Medicare & Medicaid Services (CMS) updated federal gui
Press Releases
Bibliography/Link Page
The AHA is involved with Advocacy work on opioid legislation. These are resources to other advocacy and policy documents on opioids.
Bibliography/Link Page
Ending the opioid epidemic requires a coordinated community response. Hospitals and health systems are actively partnering with organizations and people in…
Bibliography/Link Page
The resources below are guidelines to help prevent against diversion in hospitals and communities.
Bibliography/Link Page
According to the CDC, each day more than 1,000 people are treated in emergency departments for misusing prescription opioids. Even though patients may be…